Cardiac myosin heavy chain gene regulation by thyroid hormone involves altered histone modifications

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 299, Issue 6, 2010, Pages

  Haddad, F ^a   Jiang, W ^a   Bodell, P W ^a   Qin, A X ^a   Baldwin, K M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chromatin immunoprecipitation quantitative polymerase chain reaction; Epigenetic regulation; Gene transcription; Noncoding RNA; Sprague Dawley rats

Indexed keywords

HISTONE H3; MESSENGER RNA; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; PROPYLTHIOURACIL; SPACER DNA; THYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE REARRANGEMENT; GENETIC TRANSCRIPTION; HEART LEFT VENTRICLE; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MODIFICATION; QUANTITATIVE ANALYSIS; RAT; TRANSCRIPTION INITIATION SITE;

ACETYLATION; ANIMALS; BINDING SITES; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; DISEASE MODELS, ANIMAL; DNA, INTERGENIC; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION; HISTONES; HYPERTHYROIDISM; HYPOTHYROIDISM; METHYLATION; MYOCARDIUM; MYOSIN HEAVY CHAINS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; PROPYLTHIOURACIL; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, SPRAGUE-DAWLEY; RNA PRECURSORS; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC; TRIIODOTHYRONINE; VENTRICULAR MYOSINS;

EID: 78649747015     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00644.2010     Document Type: Article

References (73)

1. Alpert NR, Mulieri LA. Functional consequences of altered cardiac myosin isoenzymes. Med Sci Sports Exerc 18: 309-313, 1986.
2. Aoyagi S, Archer TK. Dynamics of coactivator recruitment and chromatin modifications during nuclear receptor mediated transcription. Mol Cell Endocrinol 280: 1-5, 2008.
3. Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev 81: 1269-1304, 2001.
4. Baldwin KM, Haddad F. Effects of different activity and inactivity paradigms on myosin heavy chain gene expression in striated muscle. J Appl Physiol 90: 345-357, 2001.
5. Black BL, Olson EN. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol 14: 167-196, 1998.
6. Brinkman AB, Roelofsen T, Pennings SWC, Martens JHA, Jenuwein T, Stunnenberg HG. Histone modification patterns associated with the human X chromosome. EMBO Rep 7: 628-634, 2006.
7. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90: 569-580, 1997.
8. Chen JD, Evans RM. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377: 454-457, 1995.
9. Clayton AL, Hazzalin CA, Mahadevan LC. Enhanced histone acetylation and transcription: a dynamic perspective. Mol Cell 23: 289-296, 2006.
10. Collingwood T, Urnov F, Wolffe A. Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. J Mol Endocrinol 23: 255-275, 1999.
11. Danzi S, Dubon P, Klein I. Effect of serum triiodothyronine on regulation of cardiac gene expression: role of histone acetylation. Am J Physiol Heart Circ Physiol 289: H1506-H1511, 2005.
12. Danzi S, Klein S, Klein I. differential regulation of the myosin heavy chain genes α and β in rat atria and ventricles: role of antisense RNA. Thyroid 18: 761-768, 2008.
13. Dinger ME, Amaral PP, Mercer TR, Pang KC, Bruce SJ, Gardiner BB, Askarian-Amiri ME, Ru K, Solda G, Simons C, Sunkin SM, Crowe ML, Grimmond SM, Perkins AC, Mattick JS. Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. Genome Res 18: 1433-1445, 2008.
14. Edwards JG, Bahl JJ, Flink IL, Cheng SY, Morkin E. Thyroid hormone influences beta myosin heavy chain (beta MHC) expression. Biochem Biophys Res Commun 199: 1482-1488, 1994.
15. Fischle W, Wang Y, Allis CD. Histone and chromatin cross-talk. Curr Opin Cell Biol 15: 172-183, 2003.
16. Fitzsimons DP, Herrick RE, Baldwin KM. Isomyosin distributions in rodent muscles: effects of altered thyroid state. J Appl Physiol 69: 321-327, 1990.
17. Flink IL, Morkin E. Interaction of thyroid hormone receptors with strong and weak cis-acting elements in the human alpha-myosin heavy chain gene promoter. J Biol Chem 265: 11233-11237, 1990.
18. Fuks F. DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev 15: 490-495, 2005.
19. Glass CK, Rosenfeld MG. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14: 121-141, 2000.
20. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130: 77-88, 2007.
21. Haddad F, Bodell PW, Qin AX, Giger JM, Baldwin KM. Role of antisense RNA in coordinating cardiac myosin heavy chain gene switching. J Biol Chem 278: 37132-37138, 2003.
22. Haddad F, Bodell PW, Qin AX, Jiang W, Giger JM, Baldwin KM. Intergenic transcription and developmental regulation of cardiac myosin heavy chain genes. Am J Physiol Heart Circ Physiol 294: H29-H40, 2008.
23. Haddad F, Qin A, Giger J, Guo H, Baldwin K. Potential pitfalls in the accuracy of analysis of natural sense-antisense RNA pairs by reverse transcription-PCR. BMC Biotechnol 7: 21, 2007.
24. Haddad F, Qin AX, McCue SA, Baldwin KM. Thyroid receptor plasticity in striated muscle types: effects of altered thyroid state. Am J Physiol Endocrinol Metab 274: E1018-E1026, 1998. (Pubitemid 28308787)
25. Hager GL, Nagaich AK, Johnson TA, Walker DA, John S. Dynamics of nuclear receptor movement and transcription. Biochim Biophys Acta 1677: 46-51, 2004.
26. Heard E, Disteche CM. Dosage compensation in mammals: fine-tuning the expression of the X chromosome. Genes Dev 20: 1848-1867, 2006.
27. Hinojos CAD, Sharp ZD, Mancini MA. Molecular dynamics and nuclear receptor function. Trends Endocrinol Metab 16: 12-18, 2005.
28. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377: 397-404, 1995.
29. Huang WY, Liew CC. Chromatin remodelling of the cardiac beta-myosin heavy chain gene. Biochem J 330: 871-876, 1998.
30. Huang WY, Liew CC. Chromatin structure and cardiac gene expression. J Mol Cell Cardiol 30: 1673-1681, 1998.
31. Izumo S, Mahdavi V. Thyroid hormone receptor alpha isoforms generated by alternative splicing differentially activate myosin HC gene transcription. Nature 334: 539-542, 1988.
32. Jackowski G, Liew CC. Fractionation of rat ventricular nuclei. Biochem J 188: 363-373, 1980.
33. Jenuwein T, Allis CD. Translating the HISTONE CODE. Science 293: 1074-1080, 2001.
34. Johnson CA, Turner BM. Histone deacetylases: complex transducers of nuclear signals. Semin Cell Dev Biol 10: 179-188, 1999.
35. Kalakonda N, Fischle W, Boccuni P, Gurvich N, Hoya-Arias R, Zhao X, Miyata Y, MacGrogan D, Zhang J, Sims JK, Rice JC, Nimer SD. Histone H4 lysine 20 monomethylation promotes transcriptional repression by L3MBTL1. Oncogene 27: 4293-4304, 2008.
36. Klein I, Ojamaa K. Thyroid hormone and the heart. Am J Med 101: 459-460, 1996.
37. Kohlmaier A, Savarese F, Lachner M, Martens J, Jenuwein T, Wutz A. A chromosomal memory triggered by Xist regulates histone methylation in X inactivation. PLoS Biol 2: e171, 2004.
38. Kornberg RD, Lorch Y. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 98: 285-294, 1999.
39. Lee CK, Shibata Y, Rao B, Strahl BD, Lieb JD. Evidence for nucleosome depletion at active regulatory regions genome-wide. Nat Genet 36: 900-905, 2004.
40. Lee JT. Lessons from X-chromosome inactivation: long ncRNA as guides and tethers to the epigenome. Genes Dev 23: 1831-1842, 2009.
41. Li J, Lin Q, Yoon HG, Huang ZQ, Strahl BD, Allis CD, Wong J. Involvement of histone methylation and phosphorylation in regulation of transcription by thyroid hormone receptor. Mol Cell Biol 22: 5688-5697, 2002.
42. Mahdavi V, Chambers AP, Nadal-Ginard B. Cardiac alpha- and beta-myosin heavy chain genes are organized in tandem. Proc Natl Acad Sci USA 81: 2626-2630, 1984.
43. Mattick JS. The genetic signatures of noncoding RNAs. PLoS Genet 5: e1000459, 2009.
44. Mattick JSAP, Dinger ME, Mercer TR, Mehler MF. RNA regulation of epigenetic processes. Bioessays 31: 51-59, 2009.
45. Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet 15, Suppl 1: R17-R29, 2006.
46. Mattick JS, Taft RJ, Faulkner GJ. A global view of genomic information - moving beyond the gene and the master regulator. Trends Genet 26: 21-28, 2010.
47. Morkin E. Control of cardiac myosin heavy chain gene expression. Microsc Res Tech 50: 522-531, 2000.
48. Munshi A, Shafi G, Aliya N, Jyothy A. Histone modifications dictate specific biological readouts. J Genet Genomics 36: 75-88, 2009.
49. Oetting A, Yen PM. New insights into thyroid hormone action. Best Pract Res Clin Endocrinol Metab 21: 193-208, 2007.
50. Pandorf CE, Haddad F, Wright C, Bodell PW, Baldwin KM. Differential epigenetic modifications of histones at the myosin heavy chain genes in fast and slow skeletal muscle fibers and in response to muscle unloading. Am J Physiol Cell Physiol 297: C6-C16, 2009.
51. Qureshi IA, Mattick JS, Mehler MF. Long non-coding RNAs in nervous system function and disease. Brain Res 1338: 20-35, 2010.
52. Rayasam GV, Elbi C, Walker DA, Wolford R, Fletcher TM, Edwards DP, Hager GL. Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro. Mol Cell Biol 25: 2406-2418, 2005.
53. Sado T, Hoki Y, Sasaki H. Tsix silences Xist through modification of chromatin structure. Dev Cell 9: 159-165, 2005.
54. Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai MJ, O'Malley BW. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389: 194-198, 1997.
55. Stanya K, Kao HY. New insights into the functions and regulation of the transcriptional corepressors SMRT and N-CoR. Cell Div 4: 7, 2009.
56. Strahl BD, Allis CD. The language of covalent histone modifications. Nature 403: 41-45, 2000.
57. Su WY, Xiong H, Fang JY. Natural antisense transcripts regulate gene expression in an epigenetic manner. Biochem Biophys Res Commun 396: 177-181, 2010.
58. Sugiura S, Kobayakawa N, Fujita H, Momomura S, Chaen S, Sugi H. Distinct kinetic properties of cardiac myosin isoforms revealed by in vitro studies. Adv Exp Med Biol 453: 125-130, 1998.
59. Tagami T, Madison LD, Nagaya T, Jameson JL. Nuclear receptor corepressors activate rather than suppress basal transcription of genes that are negatively regulated by thyroid hormone. Mol Cell Biol 17: 2642-2648, 1997.
60. Tagami T, Park Y, Jameson JL. Mechanisms that mediate negative regulation of the thyroid-stimulating hormone alpha gene by the thyroid hormone receptor. J Biol Chem 274: 22345-22353, 1999.
61. Torchia J, Glass C, Rosenfeld MG. Co-activators and co-repressors in the integration of transcriptional responses. Curr Opin Cell Biol 10: 373-383, 1998.
62. Urnov FD, Wolffe AP. A necessary good: nuclear hormone receptors and their chromatin templates. Mol Endocrinol 15: 1-16, 2001.
63. Vakoc CR, Mandat SA, Olenchock BA, Blobel GA. Histone H3 lysine 9 methylation and HP1 are associated with transcription elongation through mammalian chromatin. Mol Cell 19: 381-391, 2005.
64. Vakoc CR, Sachdeva MM, Wang H, Blobel GA. Profile of histone lysine methylation across transcribed mammalian chromatin. Mol Cell Biol 26: 9185-9195, 2006.
65. Vanhee-Brossollet C, Vaquero C. Do natural antisense transcripts make sense in eukaryotes? Gene 211: 1-9, 1998.
66. Wang D, Xia X, Liu Y, Oetting A, Walker RL, Zhu Y, Meltzer P, Cole PA, Shi YB, Yen PM. Negative regulation of TSHα target gene by thyroid hormone involves histone acetylation and corepressor complex dissociation. Mol Endocrinol 23: 600-609, 2009.
67. Wang D, Xia X, Weiss RE, Refetoff S, Yen PM. Distinct and histone-specific modifications mediate positive versus negative transcriptional regulation of TSHα promoter. PLoS ONE 5: e9853, 2010.
68. Wiencke JK, Zheng S, Morrison Z, Yeh RF. Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells. Oncogene 27: 2412-2421, 2007.
69. Wu Y, Koenig RJ. Gene regulation by thyroid hormone. Trends Endocrinol Metab 11: 207-211, 2000.
70. Wysocka J, Swigut T, Xiao H, Milne TA, Kwon SY, Landry J, Kauer M, Tackett AJ, Chait BT, Badenhorst P, Wu C, Allis CD. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 442: 86-90, 2006.
71. Xu L, Glass CK, Rosenfeld MG. Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev 9: 140-147, 1999.
72. Yang H, Mizzen CA. The multiple facets of histone H4-lysine 20 methylation. Biochem Cell Biol 87: 151-161, 2009.
73. Yen PM, Ando S, Feng X, Liu Y, Maruvada P, Xia X. Thyroid hormone action at the cellular, genomic and target gene levels. Mol Cell Endocrinol 246: 121-127, 2006.